Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION - Stock Option Activity (Details)

v3.22.1
STOCK-BASED COMPENSATION - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Employees    
Number of options    
Outstanding at the beginning of the period (in shares) 11,122,648  
Transfer between employee and consultant (in shares) (40,118)  
Granted in acquisition (in shares) 949,893  
Forfeited (in shares) (16,053)  
Expired (in shares) (7,830)  
Exercised (in shares) (1,452,971)  
Outstanding at the end of the period (in shares) 10,635,805  
Exercisable options at the end of the period (in shares) 7,122,369  
Weighted average exercise price    
Outstanding at the beginning of the period (in USD per share) $ 0.82  
Transfer between employee and consultant (in USD per share) 0.64  
Granted in acquisition (in USD per share) 0.31  
Forfeited (in USD per share) 1.81  
Expired (in USD per share) 0.61  
Exercised (in USD per share) 0.30  
Outstanding at the end of the period (in USD per share) 0.84  
Exercisable exercise price at the end of the period (in USD per share) $ 0.56  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures    
Outstanding option, weighted average remaining contractual term (in years) 7 years 8 months 12 days 6 years 10 months 13 days
Outstanding exercisable, weighted average remaining contractual term (in years) 7 years 3 months  
Outstanding intrinsic value at the beginning of the period $ 64,818  
Outstanding intrinsic value at the end of the period 55,276  
Outstanding exercisable intrinsic value at the end of the period $ 39,000  
Consultants    
Number of options    
Outstanding at the beginning of the period (in shares) 179,627  
Transfer between employee and consultant (in shares) (40,118)  
Exercised (in shares) (69,298)  
Outstanding at the end of the period (in shares) 70,211  
Exercisable options at the end of the period (in shares) 60,516  
Weighted average exercise price    
Outstanding at the beginning of the period (in USD per share) $ 0.31  
Transfer between employee and consultant (in USD per share) 0.64  
Exercised (in USD per share) 0.30  
Outstanding at the end of the period (in USD per share) 0.49  
Exercisable exercise price at the end of the period (in USD per share) $ 0.45  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures    
Outstanding option, weighted average remaining contractual term (in years) 5 years 3 days 2 years 4 months 2 days
Outstanding exercisable, weighted average remaining contractual term (in years) 4 years 5 months 26 days  
Outstanding intrinsic value at the beginning of the period $ 1,139  
Outstanding intrinsic value at the end of the period 390  
Outstanding exercisable intrinsic value at the end of the period $ 338